Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Corporate Governance > Insider Transactions

Insider Transactions

Date Name Title Type Shares Traded Price Range
Jun 13, 2017 cohen raymond w Director Disposition (Non Open Market) 2,500 6.48
Jun 13, 2017 cohen raymond w Director Acquisition (Non Open Market) 10,000 n/a
Jun 13, 2017 gagnon gilles Director Disposition (Non Open Market) 2,500 6.48
Jun 13, 2017 gagnon gilles Director Acquisition (Non Open Market) 10,000 n/a
Jun 13, 2017 krassner stuart mitchell Director Disposition (Non Open Market) 3,523 6.48
Jun 13, 2017 krassner stuart mitchell Director Acquisition (Non Open Market) 10,000 n/a
Jun 13, 2017 lenaz luigi md Director Disposition (Non Open Market) 2,500 6.48
Jun 13, 2017 lenaz luigi md Director Acquisition (Non Open Market) 10,000 n/a
Jun 13, 2017 maida anthony e iii Director Disposition (Non Open Market) 3,523 6.48
Jun 13, 2017 maida anthony e iii Director Acquisition (Non Open Market) 10,000 n/a
Jun 13, 2017 vyas dolatrai Director Disposition (Non Open Market) 3,170 6.48
Jun 13, 2017 vyas dolatrai Director Acquisition (Non Open Market) 10,000 n/a
Jun 3, 2017 gustafson kurt a Officer Disposition (Non Open Market) 9,395 5.96
Apr 17, 2017 turgeon joseph w. Officer Disposition (Non Open Market) 8,205 6.32
Mar 28, 2017 gustafson kurt a Officer Acquisition (Non Open Market) 50,163 n/a
Mar 28, 2017 gustafson kurt a Officer Disposition (Non Open Market) 4,713 6.69
Mar 28, 2017 shrotriya rajesh c md Officer Acquisition (Non Open Market) 100,326 n/a
Mar 28, 2017 shrotriya rajesh c md Officer Disposition (Non Open Market) 6,860 6.69
Mar 28, 2017 turgeon joseph w. Officer Acquisition (Non Open Market) 66,717 n/a
Mar 28, 2017 turgeon joseph w. Officer Disposition (Non Open Market) 4,562 6.69
Showing 1-20 of 258 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13  See Next 20

Stock transaction information provided by EDGAR Online. Spectrum Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPI

Price:
7.54
Change:
+ 0.16
Day High:
7.59
Day Low:
7.34
Volume:
1,265,348
4:00 PM ET on Jun 26, 2017
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools

Print Email

Search IR